Ligand Pharmaceuticals Stock Forecast - Accumulation Distribution
| LGND Stock | USD 121.47 1.08 0.88% |
Ligand Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ligand Pharmaceuticals stock prices and determine the direction of Ligand Pharmaceuticals Incorporated's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ligand Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Ligand |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 6844.89 | 2518.63 |
| Check Ligand Pharmaceuticals Volatility | Backtest Ligand Pharmaceuticals | Trend Details |
Ligand Pharmaceuticals Trading Date Momentum
| On November 29 2024 Ligand Pharmaceuticals Incorporated was traded for 121.47 at the closing time. The top price for the day was 124.34 and the lowest listed price was 120.01 . The trading volume for the day was 57.3 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.88% . The trading delta at closing time against the current closing price is 0.73% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Ligand Pharmaceuticals to competition |
Other Forecasting Options for Ligand Pharmaceuticals
For every potential investor in Ligand, whether a beginner or expert, Ligand Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ligand Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ligand. Basic forecasting techniques help filter out the noise by identifying Ligand Pharmaceuticals' price trends.View Ligand Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Ligand Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ligand Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ligand Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ligand Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Ligand Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ligand Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ligand Pharmaceuticals stock market strength indicators, traders can identify Ligand Pharmaceuticals Incorporated entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0348 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 122.18 | |||
| Day Typical Price | 121.94 | |||
| Market Facilitation Index | 4.33 | |||
| Price Action Indicator | (1.25) | |||
| Period Momentum Indicator | (1.08) | |||
| Relative Strength Index | 64.92 |
Ligand Pharmaceuticals Risk Indicators
The analysis of Ligand Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ligand Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ligand stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.87 | |||
| Semi Deviation | 2.44 | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.22 | |||
| Downside Variance | 7.11 | |||
| Semi Variance | 5.95 | |||
| Expected Short fall | (1.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Ligand Pharmaceuticals to cross-verify your projections. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.032 | Earnings Share 2.49 | Revenue Per Share 8.509 | Quarterly Revenue Growth 0.576 | Return On Assets 0.013 |
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.